Logo - springer
Slogan - springer

Biomedical Sciences - Neuroscience | Neurotoxicity Research (Editorial Board)

We’re working on a new version of this journal site - preview it now
Neurotoxicity Research

Neurotoxicity Research

Neurodegeneration, Neuroregeneration, Neurotrophic Action, and Neuroprotection

Editor-in-Chief: Richard M. Kostrzewa

ISSN: 1029-8428 (print version)
ISSN: 1476-3524 (electronic version)

Journal no. 12640

80,33 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

2 Volume(-s) with 8 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy


Richard M. KostrzewaDepartment of  Biomedical Sciences, Quillen College of Medicine, East Tennessee State Univ., Johnson City TN, USA




Mario Herrera-MarschitzProgram of Molecular and Clinical Pharmacology, University of Chile, Santiago, Chile

Xin-Fu ZhouSchool of Pharmacy and Medical Sciences, Faculty of Health Sciences, University of South Australia, Adelaide, Australia




Lucyna Antkiewicz-MichalukDepartment of Neurochemistry, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Marta C. AntonelliInstituto de Biología Celular y Neurociencias "Prof. E. De Robertis", CONICET-UBA, Universidad de Buenos Aires, Argentina

Trevor ArcherDepartment of Psychology, Universities of Göteborg and Kalmar, Sweden

Masato AsanumaDepartment of Brain Sciences, Okayama University, Graduate School of Medicine, Dentistry & Pharmaceutical Sciences, Japan

Rommy von BernhardiDepartamento de Neurología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

Rryszard BrusDepartment of Nursing, High School of Strategic Planning, Dabrowa Gornicza, Poland

Vladimir L. BuchmanSchool of Biosciences, Cardiff University, Cardiff, UK

Anna R. CartaDepartment of Biomedical Sciences, University of Cagliari, Italy

Jean Lud CadetMolecular Neuropsychiatry Research Branch, DHHS/NIH/NIDA Intramural Research Program, NIH, Baltimore, MD, USA

Sandra CeccatelliDepartment of Neuroscience, Karolinska Institutet, Stockholm, Sweden

Michael A. CollinsDepartment of Molecular Pharmacology & Therapeutics, Loyola University, Chicago, Stritch School of Medicine, Maywood, IL, USA

Cynthia A. CrawfordDepartment of Psychology, California State University, San Bernardino, CA, USA

Wojciech DanyszMerz Pharmaceuticals GmbH, Frankfurt/Main, Germany

Elaine Del-BelDepartment of Morphology Physiology & Basic Pathology, Dental School of Ribeirão Preto, University of São Paulo,  Brazil

Malgorzata FilipLaboratory of Drug Addiction Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Fabio FumagalliDipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy

Raul GainetdinovDepartment of Neuroscience & Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy; Skolkovo Institute of Science & Technology, Moscow Region, Russia; Institute of Translational Biomedicine, St. Petersburg State University, Russia

Krystyna Gołembiowska, Department of Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Gilles GuilleminNeuropharmacology Group, MND & Neurodegenerative Diseases Research Center, Macquarie University, Sydney, Australia

G. Jean HarryNeurotoxicology Group, National Toxicology Program Laboratory, NIEHS/NIH, Research Triangle Park, NC, USA

Maria-Trinidad Herrero Ezquerro, Clinical & experimental Neuroscience, Department of Human Anatomy & Psychobiology, University of Murcia, Spain
Danuta JantasDepartment of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Kraków, Poland

Kristen A. KeefeInterdepartmental Program in Neuroscience, University of Utah, Salt Lake City, UT, USA

Władysław Lasoń, Department of Experimental Neuroendocrinology, Director – Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland

J. William LangstonParkinson's Institute and Clinical Center, Sunnyvale, CA, USA

Giovanni LaviolaDepartment of Cell Biology and Neuroscience, Section of Behavioural Neuroscience, Istituto Superiore di Sanità Roma, Italy

Italo MocchettiDepartment of Neuroscience, Laboratory of Preclinical Neurobiology, Georgetown University Medical Center, Washington, DC, USA

Rosario MoratallaInstituto Cajal, CSIC and 5CIBERNED, Instituto de Salud Carlos III, Madrid, Spain

Micaela MorelliDeparment of Biomedical Sciences, Section of Neuropsychopharmacology, University of Cagliari; Institute of Neuroscience, Cagliari, Italy

Hiroku NawaDepartment of Molecular Biology, Brain Research Institute, Niigata University, Niigata, Japan

Tomas PalomoPsychiatry Deparment, Laboratory of Neurosciences, Instituto de Investigación Sanitaria del Hospital Universitario, Madrid, Spain; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), ISCIII, Spain

Rui D. PredigerDepartamento de Farmacologia, Centro de Ciências Biológicas, Universidade Federal de Santa Catarina, Florianópolis, Brazil

Rita Raisman-VozariINSERM, Thérapeutique Expérimentale de la Neurodégénérescence, Hôpital de la Salpetrière -ICM , Paris, France

Dora ReglodiDepartment of Anatomy, MTA-PTE PACAP Lendulet Research Group, Medical School, University of Pecs, Pecs, Hungary

Peter RiedererCenter of Mental Health, Clinic and Policlinic for Psychiatry, Psychosomatics and Psychotherapy, University of Würzburg, Germany

Richard SalviCenter for Hearing and Deafness, State University of New York at Buffalo, Buffalo, NY, USA

Abel Santamaria, Head – Lab de Aminoácidos Excitadores, Inst Nacional de Nueorlogía y Neurocirurgía Insurgentes, Mexico City, Mexico

Arne SchousboeDepartment of Drug Design and Pharmacology, Faculty of Health and Medicine, University of Copenhagen, Denmark

Juan Segura-AguilarDepartment of Molecular and Clinical Pharmacology, Faculty of Medicine, University of Chile, Santiago, Chile

Nadia StefanovaDivision of Neurobiology, Department of Neurology, Innsbruck Medical University,  Innsbruck, Austria

Harry W.M. Steinbusch, Department of Cellular Neuroscience, Faculty of Health, Medicine & Life Sciences, Maastricht University, Netherlands

Yousef TizabiDepartment of Pharmacology, Howard University College of Medicine, Washington, DC, USA

Moacir WajnerServiço de Genética Médica, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil

Yanjiang WangDepartment of Neurology & Centre for Clinical Neuroscience, Third Military Medical University, Chongqing, China

Orly WeinrebEve Topf Center, Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel

Xingshun XuJiangsu Key Laboratory of Translational Research and Therapy for Neuro-Psycho-Diseases and Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China

Luigi ZeccaInstitute of Biomedical Technologies, National Research Council of Italy, Segrate, Milan, Italy

Read this Journal on Springerlink

For authors and editors

  • Journal Citation Reports®
    2018 Impact Factor
  • 3.311
  • Aims and Scope

    Aims and Scope


    Neurotoxicity Research is an international, interdisciplinary broad-based journal for reporting both basic and clinical research on classical neurotoxicity effects and mechanisms associated with neurodegeneration, necrosis, neuronal apoptosis, nerve regeneration, neurotrophin mechanisms, and topics related to these themes.

    Published papers have focused on:


    Neuronal apoptosis
    Neuronal necrosis
    Neural death processes (anatomical, histochemical, neurochemical)
    Neurodegenerative Disorders
    Neural Effects of Substances of Abuse


    Neural Adaptations
    Neurotrophin mechanisms and actions


    Excitatory amino acids
    Neurotoxins, endogenous and synthetic
    Reactive oxygen (nitrogen) species
    Neuroprotection by endogenous and exogenous agents

    Papers on related themes are welcome.

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for Authors

    Instructions for Authors


  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.

    © Springer Science+Business Media New York

Services for the Journal

Alerts for this journal


Get the table of contents of every new issue published in Neurotoxicity Research.